Skip to main content
SpringerLink
Log in

Introducing birth-dose hepatitis B vaccination would be cost effective in Burkina Faso

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Gosset A, et al. Cost-effectiveness of adding a birth dose of hepatitis B vaccine in the Dafra district of the Hauts-Bassins Region in Burkina Faso (NeoVac Study). Vaccine : 5 Jul 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2021.06.059

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Introducing birth-dose hepatitis B vaccination would be cost effective in Burkina Faso. PharmacoEcon Outcomes News 883, 21 (2021). https://doi.org/10.1007/s40274-021-7892-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7892-8

Search

Navigation